Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-Steroidal Anti-Inflammatory Drugs

This study has been terminated.
(The Principal Investigator is no longer affiliated with the Study Site.)
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Medstar Research Institute
ClinicalTrials.gov Identifier:
NCT00443963
First received: March 6, 2007
Last updated: December 17, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2007
  Estimated Primary Completion Date: No date given